LCA5 and retinal ciliopathy: There are now several more genes being targeted for gene therapy in retinal ciliopathies including CEP290 (mutations in which cause LCA10) (Estrada-Cuzcano et al., 2012; Burnight et al., 2014; Zhang et al., 2018); and LCA5 (Song et al., 2018).